Mike is the CEO of Genomenon, a genomics intelligence company that is leading the race in curating the entire human genome. Genomenon improves the quality of patients’ lives by characterizing the genomic drivers of genetic disease and cancer. Blending the power of AI with the precision of genomic expertise, Genomenon simplifies complex genetic data into actionable insights to put at the fingertips of clinicians to diagnose patients suffering from rare diseases and cancer, and researchers to create precision medicine targeted at these diseases.Mike is a 4-time serial entrepreneur with 30 years of CEO experience starting, building and growing high tech, software companies and several successful exits.